Robbins Umeda LLP, a shareholder rights litigation firm, is interested in helping shareholders of drugstore.com, inc. The firm has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the board of directors of drugstore.com, inc. (NASDAQ: DSCM) in connection with their efforts to sell drugstore.com to Walgreen Co. (NYSE: WAG).

If you own stock in drugstore.com and would like more information about your rights as a shareholder, please contact Gregory E. Del Gaizo at 800-350-6003 or via the shareholder information form on our website.

On March 24, 2011, drugstore.com announced it has entered into a definitive merger agreement under which Walgreens will acquire all of the outstanding common shares of drugstore.com. Under the current agreement, drugstore.com shareholders will receive $3.80 in cash for each share of drugstore.com common stock they hold. The transaction is expected to close by the end of June 2011.

The investigation is focused on whether drugstore.com's board of directors is undertaking a fair process to obtain maximum value for its shareholders. Notably, on February 8, 2011, drugstore.com reported strong sales figures of $123.6 million, beating consensus estimates of $120.6 million. Additionally, the merger agreement contains a termination fee over $15 million, which drugstore.com will have to pay under certain circumstances, such as the board of directors agreeing to a higher offer.

Robbins Umeda LLP represents individual and institutional shareholders in derivative, direct, and class action lawsuits. The law firm's skilled litigation teams include former federal prosecutors, former defense counsel from top multinational corporate law firms, and career shareholder rights attorneys. Robbins Umeda LLP has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. For more information, please go to http://www.robbinsumeda.com.

Press release link: http://www.robbinsumeda.com/shareholders-rights-blog/drugstore-com/

Attorney Advertising. Past results do not guarantee a similar outcome.

Drugstore (NASDAQ:DSCM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Drugstore.
Drugstore (NASDAQ:DSCM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Drugstore.